Outcomes of cutaneous surgery for nonmelanoma skin cancer in patients with different Fitzpatrick skin types: A nationwide, multicenter, prospective study
- PMID: 38296200
- DOI: 10.1016/j.jaad.2023.11.069
Outcomes of cutaneous surgery for nonmelanoma skin cancer in patients with different Fitzpatrick skin types: A nationwide, multicenter, prospective study
Keywords: Fitzpatrick; cancer; cutaneous; multicenter; nonmelanoma; outcomes; patients; prospective; skin; skin of color; surgery.
Conflict of interest statement
Conflicts of interest Dr Bolotin reported serving as principal investigator on a clinical trial sponsored by Replimune outside the submitted work. Dr Cohen reported serving as a clinical investigator, consultant, or speaker or trainer for Accure, Allergan, Almirall/Athenex, Avuta, Biofrontera Bioscience, Biopelle, Brickell Biotech, Croma, Elta, Endo Pharmaceuticals, Ferndale, Galderma, InMode, IntraDerm, Lutronic, Merz, Novan, PCA, Pulse Biosciences, Raziel, Recros Medica, Revance, Revision, Sciton, and Sente outside the submitted work. Dr Council reported receiving personal fees from Sanofi Genzyme Regeneron, AbbVie, and Castle Biosciences outside the submitted work. Dr Riley has served as an advisory board member for Novartis Pharmaceuticals. The other authors have no conflicts of interest to declare.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
